This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World ...ribute-to-highlight medbox">Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expanding access to affordable antiretroviral therapy (ART).
The report is supplemented by 11 drug profiles that contain more detailed information on pricing trends and patent barriers for key antiretroviral drugs and fixed-dose combinations. Also included is an annex of conditions that define eligibility for reduced prices from 15 pharmaceutical companies.
more
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision ...highlight medbox">of HIV/Aids, malaria and tuberculosis medicines. It describes how PS functions in the country, what actors are involved in this area and the relations among them, pursuing salient issues in the modus operandi of partners in cooperation.
more
National Tuberculosis and Leprosy Conrol Programme
Data from the 2000, 2005, and 2011 Ethiopia Demographic and Health Surveys | This report examines trends in key demographic indicators among youth ...from the findings of the 2000, 2005, and 2011 Ethiopia Demographic and Health Surveys (EDHS).
more
This expansive facilitator's guide deals with psychosocial interventions concerning multiple causes of trauma such as HIV and ...e-to-highlight medbox">AIDS and post-conflict situations. The guide offers technical advice to the implementor which is usefully augmented by diagrams, ideas for games and other useful interventions
more
Usage Guidelines
Junior and Senior Secondary
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview o...f the patent landscape with respect to a select number of ARV medicines in developing countries as of April 2014. The focus is primarily on those ARVs that are recommended by the World Health Organization (WHO) as well as new ARVs that have either recently obtained regulatory approval or are in phase III clinical trials.
more
Accessed online January 2018
Regulation of the Minister of Health of the Republic ...>of Indonesia on Guidelines for Antiretroviral Treatment
more